Sunday | Dec 22 2024 |
The collaboration focuses on conducting validation studies on Trucan's next-generation cancer diagnostic tests, which leverage advanced techniques such as next-generation sequencing and biomarker-driven diagnostics
Subscribe to our newsletter to get updates on our latest news
